Spectrofluorimetric determination of paroxetine hydrochloride in its formulations and human plasma.

A sensitive spectrofluorimetric procedure for the determination of paroxetine-HCl in pharmaceutical formulations and human plasma has been described. The native fluorescence of the drug has been studied under different conditions. Maximum fluorescence intensity was obtained in methanol at 340 nm using 290 nm for excitation. Different surfactants showed negative effect on the fluorescence intensity of paroxetine-HCl. Regression analysis of Beer's plot showed good correlation (r=0.9999) between fluorescence intensity and concentration over the range of 0.05-0.40 microg ml-1 with lower limit of detection (LOD) of 0.015 microg ml-1. The drug was successfully determined in its tablets with average % recovery of 98.00+/-0.99% which was in accordance with those given by a compendial method. The method was also applied to the determination of paroxetine-HCl in spiked human plasma with average recovery of 77.70+/-1.06%.

[1]  M. J. Villaseñor,et al.  Development of a capillary gas chromatographic procedure , 2004 .

[2]  K. Armbrust,et al.  Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions , 2004, Environmental toxicology and chemistry.

[3]  A. Polettini,et al.  A rapid screening procedure for drugs and poisons in gastric contents by direct injection-HPLC analysis. , 2004, Forensic science international.

[4]  J. Nevado,et al.  Development of a capillary zone electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method. , 2004 .

[5]  G. O. Reddy,et al.  Enantiomeric separation of the key intermediate of paroxetine using chiral chromatography. , 2003, Journal of pharmaceutical and biomedical analysis.

[6]  G. Altiokka,et al.  Simple Method of Paroxetine Determination Usinga Single Channe lFIA with No In-line Reaction Process , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[7]  D. Coleman,et al.  Statistics in analytical chemistry-Part 6: Calibration design , 2003 .

[8]  S. Fanali,et al.  Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis , 2002 .

[9]  Aysel Öztunç,et al.  7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants. , 2002 .

[10]  E. Lundanes,et al.  Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[11]  C. Eap,et al.  Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. , 1998, Journal of chromatographic science.

[12]  J. D. Hinchen.  Statistics in Analytical Chemistry , 1967 .